Company intelligence / Profile preview

Dolon

London, United Kingdomdolon.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Dolon provides strategic pricing and market access consultancy services for rare disease and oncology medicines. The company supports biopharma clients in demonstrating value and optimizing reimbursement for their pipeline and marketed products. It has contributed to major industry reports such as the EFPIA "Dolon Report" on European pharma legislation impacts.

Therapeutic areas: OncologyRare Diseases
Modalities: Not applicable (consultancy; does not develop therapeutics directly)
Industry: Consulting

Partnerships

European Federation of Pharmaceutical Industries and Associations (EFPIA) – commissioned major policy report

Beyond the preview

Go deeper on Dolon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolon.

Explore the full profile